Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Santhera Pharmaceuticals Holdings Ltd. (OTC: SPHDF).

Full DD Report for SPHDF

You must become a subscriber to view this report.

Recent News from (OTC: SPHDF)

Santhera Pharmaceuticals reports 9M results
Santhera Pharmaceuticals ( OTCPK:SPHDF ): 9M GAAP EPS of -CHF6.19. More news on: Santhera Pharmaceuticals Holdings Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: December, 12 2018 01:41
Santhera Pharmaceuticals Holdings Ltd. 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by Santhera Pharmaceuticals Holdings Ltd. in conjunction with their 2018 Q2 earnings Read more ...
Source: SeekingAlpha
Date: September, 05 2018 13:16
Santhera Pharmaceuticals reports 1H results
Santhera Pharmaceuticals ( OTCPK:SPHDF ): 1H GAAP EPS of -CHF4.25. More news on: Santhera Pharmaceuticals Holdings Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: September, 04 2018 01:33
Mereo BioPharma Proposes Terms For U.S. IPO
Quick Take Mereo BioPharma ( OTC:MREO ) intends to raise $70 million from the sale of 4 million ADSs in a U.S. IPO and European private placement. The company is developing a pipeline of in-licensed drugs from Novartis ( NVS ) and AstraZeneca ( AZN ). MREO is taking an unorthodox approac...
Source: SeekingAlpha
Date: April, 09 2018 10:54
Mereo BioPharma Group Files For U.S. IPO
Quick Take Mereo BioPharma Group ( MREO ) intends to sell ADSs for gross proceeds of $80.5 million from a U.S. IPO, according to an F-1 registration statement . The firm is a specialty biopharmaceutical company focused on the acquisition and rapid development of innovative medicines t...
Source: SeekingAlpha
Date: March, 27 2018 19:58


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on SPHDF.

About Santhera Pharmaceuticals Holdings Ltd. (OTC: SPHDF)

Logo for Santhera Pharmaceuticals Holdings Ltd. (OTC: SPHDF)

Not available


Contact Information



Current Management

  • Barbara Heller / CFO
  • Thomas Staffelbach / VP, Investor Rel.

Current Share Structure

  • Market Cap: $100,698,429 - 03/16/2018
  • Issue and Outstanding: 3,660,430 - 08/29/2011


Daily Technical Chart for (OTC: SPHDF)

Daily Technical Chart for (OTC: SPHDF)

Stay tuned for daily updates and more on (OTC: SPHDF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: SPHDF)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

DD Report



Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in SPHDF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of SPHDF and does not buy, sell, or trade any shares of SPHDF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: